Clinical Trial Update: A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Mibavademab to treat obesity caused by LEP gene mutations, involving children, adolescents, and adults, sponsored by Regener…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monogenic Obesity

Drugs mentioned

• Mibavademab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Monogenic Obesity | Phase 3 | Status: RECRUITING